Horizon Pharma (HZNP) Tops Q3 EPS by 30c; Boosts FY15 Revenue Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/25/2026
- Nasdaq, S&P end lower as tech stocks fall
- Micron posts record profit as AI memory demand fuels explosive growth
- Brent settles at lowest since before start of Iran war as more tankers exit Hormuz
- All eyes on Micron earnings tonight as sell-off raises stakes for AI memory trade
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
Mizuho Bullish on Horizon Pharma (HZNP) Into Today's Investor Day
November 9, 2015 6:51 AM ESTHorizon Pharma (NASDAQ: HZNP) is hosting its analyst day today at 11:30 and will offer short and long term guidance as it grows increasingly focused on its Orphan franchise. The analyst day will be key to drawing distinctions between Horizon's and Valeant's specialty pharma models. PBMs... More
Guggenheim Shows Increasing Confidence in Horizon Pharma (HZNP) Following 3Q Beat; Reiterates Buy
November 6, 2015 11:10 AM ESTGuggenheim reiterated a Buy rating and $40.00 price target on Horizon Pharma (NASDAQ: HZNP) following the company's 3Q15 earnings report. HZNP reported adjusted diluted 3Q15 EPS of $0.70, $0.29 above consensus. The company also raised its '15 EBITDA guidance to $350MM-$360MM from $265MM-$280MM, consensus was... More
